The Validity and Reliability of the Turkish Version of the CPAQ-8
1 other identifier
observational
80
1 country
1
Brief Summary
Acceptance of chronic pain is becoming an increasingly important issue in the field of pain management. Many researchers argue that patients who accept pain better function better both physically and psychologically. In many countries, the Chronic Pain Acceptance Questionnaire - 8 (CPAQ-8) has been frequently validated and used to measure the pain acceptance of patients with chronic pain.1 However, the CPAQ-8 has not yet been introduced and validated in Turkey. In this study, we aimed to translate the English version of CPAQ-8 into Turkish, make correct cross-cultural adaptations, and validate the psychometric properties of the Turkish version of CPAQ-8 by testing it in Turkish fibromyalgia patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedFirst Submitted
Initial submission to the registry
February 12, 2022
CompletedFirst Posted
Study publicly available on registry
February 23, 2022
CompletedMarch 14, 2022
February 1, 2022
Same day
February 12, 2022
February 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Fibromyalgia Impact Questionnaire
The Fibromyalgia Impact Questionnaire was used to measure patients' symptom severity and functional status. There are 10 items in the FIQ; each item gets a score between 0-10. The first item questions the ability to perform activities of daily living with 11 questions. Other items question general well-being, ability to work, and symptoms of pain, fatigue, stiffness, anxiety, and depression. The score range is 0 to 100; higher scores indicate severe disease.
01.01.2020-31.12.2021
Secondary Outcomes (3)
Hospital Anxiety and Depression Scale
01.01.2020-31.12.2021
Tampa Scale of Kinesiophobia
01.01.2020-31.12.2021
Brief Pain Inventory
01.01.2020-31.12.2021
Interventions
The aim of this study is to test the validity of the Turkish version of the Chronic Pain Acceptance Questionnaire-8 (CPAQ-8).
Eligibility Criteria
Patients who applied to our physical medicine and rehabilitation outpatient clinic, agreed to participate in the study, were over the age of 18, had at least primary school education, were diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria, and could speak and communicate in Turkish were included in the study.
You may qualify if:
- Patients who applied to our physical medicine and rehabilitation outpatient clinic,
- Agreed to participate in the study, were over the age of 18,
- Had at least primary school education, were diagnosed with fibromyalgia syndrome according to the 2016 American College of Rheumatology (ACR) criteria,
- Could speak and communicate in Turkish were included in the study.
You may not qualify if:
- Those who did not agree to participate in the study,
- \<18 years old, and could not communicate in Turkish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmet Kıvanç Menekşeoğlu
Istanbul, 34015, Turkey (Türkiye)
Related Publications (3)
Fish RA, Hogan MJ, Morrison TG, Stewart I, McGuire BE. Willing and able: a closer look at pain Willingness and Activity Engagement on the Chronic Pain Acceptance Questionnaire (CPAQ-8). J Pain. 2013 Mar;14(3):233-45. doi: 10.1016/j.jpain.2012.11.004.
PMID: 23452647BACKGROUNDFish RA, McGuire B, Hogan M, Morrison TG, Stewart I. Validation of the chronic pain acceptance questionnaire (CPAQ) in an Internet sample and development and preliminary validation of the CPAQ-8. Pain. 2010 Jun;149(3):435-443. doi: 10.1016/j.pain.2009.12.016. Epub 2010 Feb 25.
PMID: 20188472RESULTKleinebrecht J, Degenhardt KH, Franz J, Schneider G. Variability of limb malformations induced by 5-fluoro-2'-deoxycytidine in mice. Teratology. 1972 Jun;5(3):295-301. doi: 10.1002/tera.1420050304. No abstract available.
PMID: 5032639RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmet K Menekşeoğlu
Kanuni Sultan Süleyman Research and Training Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 12, 2022
First Posted
February 23, 2022
Study Start
January 1, 2020
Primary Completion
January 1, 2020
Study Completion
December 31, 2021
Last Updated
March 14, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share